Outside directorships held concurrently by representative directors
First written in FY2020. 2 of 5 entries say "Softened", first in FY2022. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「Okamoto (岡本) plans to continue serving concurrently as an officer of the group for the time being, to the extent that this does not interfere with the performance of duties as the Company's representative director. However, if a serious problem arises in the group's management, Okamoto (岡本) may be required to deal with the group's response regardless of Okamoto's (岡本) intentions, which could temporarily affect the execution of business by the Company Group.」
The representative director plans to continue holding concurrent directorships at other companies for the time being, and the potential impact on business execution if problems arise in the other group continues to be disclosed. - FY2023SoftenedAnnual report
「The concurrent appointments as officers of HMBC株式会社 and HIBC株式会社 are scheduled to end as soon as practicable.」
The specific plan disclosed in the previous fiscal year to end the concurrent appointments by March 2023 has become the open-ended wording “as soon as practicable” in the current filing. - FY2022SoftenedAnnual report
「The Company conducted remote interviews and other selection procedures to identify successors ahead of Okamoto's (岡本) planned departure by the annual general meetings of shareholders of HMBC株式会社 and HIBC株式会社 in March 2022. However, no successor officer has yet been appointed and the concurrent appointments have not ended. Okamoto (岡本) plans to change from holding the concurrent appointments to no longer holding them by the annual general meetings of shareholders of HMBC株式会社 and HIBC株式会社 in March 2023. However, if the prolonged spread of COVID-19 prevents the selection of suitable successors from progressing as expected, the date of departure may be extended.」
The planned ending of the concurrent appointments by March 2022 was not achieved, and the planned departure was postponed until March 2023. - FY2021Clarification of the deadline for ending concurrent appointments and the possibility of postponementAnnual report
「Okamoto (岡本) plans to change from serving concurrently as an officer of HMBC株式会社 and HIBC株式会社 to no longer holding those positions by the annual general meetings of shareholders of HMBC株式会社 and HIBC株式会社 in March 2022. However, if the prolonged spread of COVID-19 prevents the selection of suitable successors from progressing as expected, the date of departure may be extended.」
While the planned timing for ending the concurrent appointments was specified as no later than the annual general meetings of shareholders in March 2022, the disclosure also stated that this could be postponed depending on the selection of successors. - FY2020First statedAnnual report
「Okamoto (岡本) plans to continue serving concurrently as an officer of the group for the time being, to the extent that this does not interfere with the performance of duties as the Company's representative director. However, if a serious problem arises in the group's management, Okamoto (岡本) may be required to deal with the group's response regardless of Okamoto's (岡本) intentions, which could temporarily affect the execution of business by the Company Group.」
The disclosure identifies as a risk the possibility that the representative director's concurrent directorships at multiple companies could affect the execution of business.